An NIH Director's Wednesday Afternoon Lecture Series
"Inflammation, CRP and Cardiovascular Risk: Is It
Time to Change the Framingham Risk Score?"
Speaker: Paul M. Ridker, MD, MPH, FACC, FAHA
Professor of Medicine, Harvard Medical School Director, Center
for Cardiovascular Disease Prevention Brigham and Women's Hospital,
Wednesday, November 2, 2005
National Institutes of Health
Videocast of lecture
For information and accommodations call Hilda Madine
at (301) 594-5595
Past Astute Clinician Lectures
"Insulin Resistance and Metabolic Syndromes: Different Names, Different Concepts, Different Goals"
November 3, 2004 - Dr. Gerald M. Reaven, M.D.
"Cochlear Implants, Past, Present, and Future,"
November 5, 2003 - Richard T. Myamoto, M.D.
"AIDS: A Window on Infectious Diseases,"
November 06, 2002 - Henry Masur, M.D.,
"STI571: A Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia (CML) Validating the Promise of Molecularly Targeted Therapy,"
November 07, 2001 - Brian Druker, M.D.
"The Patients Who Taught Me and Led to My Discoveries in Congenital Adrenal Hyperplasia,"
December 13, 2000 - Maria I. New, M.D.
"The Elucidation of Lyme Arthritis,"
November 3, 1999 - Brian Druker, M.D
"The Link Between Teratogenesis and Carcinogenesis: Lessons from the Wilms Tumor Model.,"
October 15, 1998 - Dr. J. Bruce Beckwith
NOTE: Video requires the free RealPlayer.